Navigation Links
Mindray Announces First Quarter 2009 Financial Results
Date:5/11/2009

pectively, compared to $0.23 and $0.22 in first quarter 2008. Shares used in the computation of diluted earnings per share in the first quarter 2009 were 112.1 million.

Other Select Data

Average accounts receivable days outstanding were 60 days, or $87.7 million, for the first quarter 2009 compared to 40 days, or $89.7 million, for the full year 2008. Inventory turnover was 89 days, or $57.9 million, for the first quarter 2009 compared to 60 days, or $57.5 million, for the full year 2008.

Average accounts payable days outstanding was 58 days, or $39.7 million, for the first quarter 2009 compared to 46 days or $36.5 million, for the full year 2008.

As of March 31, 2009, the company had $261.2 million in cash and cash equivalents and restricted cash. Net cash generated from operating activities and capital expenditures for the first quarter 2009 were $30.7 million and $13.6 million, respectively.

As of March 31, 2009 the company had approximately 5,620 employees compared to 4,050 employees on March 31, 2008 and 5,580 employees on December 31, 2008.

Business Outlook for Full Year 2009

With the continuing uncertainties in many parts of the market Mindray competes in, the company now expects:

    -- 2009 net revenue to grow at a rate of at least 10% year-over-year,
       provided that foreign exchange rates remain constant at RMB6.85 to the
       dollar and $1.33 to the euro.
    -- Non-GAAP EPS to grow 10% over 2008.
    -- Capital expenditure in the range of $40 million to $60 million.
    -- Share based compensation to be $12 million, based on issuances to date,
       which does not take into account of any additional share based
       compensation costs that may come later this year, if any.
    -- Amortization of intangible assets to be $10 million including April
       2006 acquisition of minority interest and May 2008 acquis
'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
3. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
4. Mindray Announces Option Exchange Offer
5. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
6. Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
7. Mindray Announces Preliminary 2008 Operating Results
8. Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference
9. Mindray Medical to Exhibit at RSNA 2008 in Chicago, from November 30th to December 4th, 2008
10. Mindray Announces 2008 Third Quarter and Nine Months Results
11. Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...RNewswire/--Whiletheholidayseasonoftenbringsfamili...anbedifficultforthosegrievingthedeathofalovedone.F...milies.Theholidayseasoncanbringadditionalchallenge...ce,ACenterforGrievingChildren,AdolescentsandTheirF...ontohavingavarietyofprintandonlineresourcesavailab...
(Date:11/24/2009)...Nov.24/PRNewswire/--Bionorica,aninternationalcompa...uncedtodaytheavailabilityofneweducationalresources...th.Atipsheeton"StayingNaturallyHealthyduringtheHol...wavailableonthecompany,swebsiteat www.bionoricausa...ubscriptiontotheNaturalMomstipsheets,withcontentco...
(Date:11/24/2009)...ewswire-FirstCall/--CenteneCorporation(NYSE: CNC )...hasselectedCenteneasoneoftwoCoordinatedCareOrganiz...ssNetwork(MississippiCAN),acoordinatedcareprogramf...gwiththeDivisiontoexecuteacontractinwhichthecompan...oliaHealthPlan(Magnolia). ,, BasedinJackson,Mis...
(Date:11/24/2009)...mproves heart prospects, but cancer risk remains ,...A new study offers yet more proof that smoking is ...nd cancer. , Researchers followed 12,152 Americ...mokers and nonsmokers for three years. During that... to die of cancer, 2.26 times more likely to die o...
(Date:11/24/2009)... have found that hormones produced during pregnanc...th of breast cancer. This protein, alpha-fetoprote...ent for the treatment and prevention of breast can...evention Research , a journal of the American Asso...gnancy, such as estrogen, all induce AFP, which di...
Breaking Medicine News(10 mins):Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Bionorica Offers Expert Resources, Health Tips for 'Natural Moms' 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Smokers Double Their Risk for Heart Disease 2Health News:Protein from pregnancy hormone may prevent breast cancer 2
... N.J., April 15 MedQuist Inc. (Nasdaq: MEDQ ) t...ts new Chief Financial Officer. He joined MedQuis...t,s new CFO, Golio is responsible for directing al.... "Dominick,s broad experience as a Chief Financi...
...uck an industry trend and boost enrollments , , D...omy struggles, many health and fitness clubs conti...nchisees of Planet Fitness, however, the fastest g...ps totaling in the six figures. , , The campaign,...
...ons Give Employees More Flexibility and Ease Admin...The Guardian Life Insurance Company of America (Gu...ary benefits for small and mid-sized companies, to...rization, providing faster, easier access to impor...
...ological differences in toddlers born to drug abus...s) -- In what researchers are calling the first st...t women has been found to prompt abnormal brain de...pert said. , "If we accept the conclusion here tha...
...N.C., April 15 TSI Healthcare, a national leader ...election and implementation, and The SURVE Consult...resource firm, have announced a strategic alliance..., TSI (and its subsidiaries) currently has approxi...
...rdt and the Council for American Medical Innovatio...tion" in Chicago, featuring David Brennan, CEO of ...IO, academics and patient advocates , , CHICAGO,...atient advocacy to address the importance of medic...
Other Medicine News:Health News:MedQuist Names Dominick J. Golio as Chief Financial Officer 2Health News:Despite Ailing Economy, Planet Fitness Thrives 2Health News:New Program Gives Guardian Dental Pre-Paid/DHMO Members Greater Access to Specialty Care 2Health News:Fetal Exposure to Methamphetamine May Harm Child's Brain 2Health News:TSI Healthcare and SURVE Consulting Announce a Strategic Alliance for Leadership and Business Development 2Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 2Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 3Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 4
(Date:11/24/2009)...ciencesCorporationannouncedtodaythattherewillbemul...rationFLT3inhibitor,inAMLatthe51stAmericanSocietyo...LA,December5-8,2009.Anoralpresentationwillhighligh...tystudyinadultswithacutemyeloidleukemia(AML).Addit...heeffectofAC220monotherapyandincombinationwithchem...
(Date:11/24/2009)...FirstCall/--CardioGenicsHoldingsInc.(OTCBulletinBo...ngtheimmunoassaysegmentoftheIVDtestingmarket,repor...gtothenextphaseofthecommercializationofCardioGenic...). ,, PertheagreementwithMerckChimiethatwasexec...ewithitsproprietarysilvercoatedparamagneticbeadsfo...
(Date:11/24/2009)...Call/--EchoTherapeutics,Inc.(OTCBulletinBoard:ECTE...Systemasanon-invasive,wireless,transdermalcontinuo...inPrepSystemfortransdermaldrugdelivery,announcedto...iveOfficer,willpresentatthe13thAnnualBiotechandSpe...orkSocietyofSecuritiesAnalysts,at2:05onDecember1,2...
Breaking Medicine Technology:Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Patch Shots May Someday Replace Injections 54893 1Patch Shots May Someday Replace Injections 54893 2Vanderbilt joins national consortium to develop new cancer therapies 54888 1Vanderbilt joins national consortium to develop new cancer therapies 54888 2Vanderbilt joins national consortium to develop new cancer therapies 54888 3American Society for Microbiology honors Anton Y Peleg 9618 1American Society for Microbiology honors Anton Y Peleg 9618 2American Society for Microbiology honors Anton Y Peleg 9618 3American Society for Microbiology honors Anton Y Peleg 9618 4
...re than 10 years, Mark Wentland, professor of chem...nic Institute , led a Rensselaer team in the disco...s with the potential to treat nervous system disor...censed to Alkermes Inc., and the company identifie...cal trials with the candidate, known as ALKS 33, b...
...en(TM), Inc. (NYSE Amex: ILE ) today announced t... ("FDA") has completed its initial review of the C...ated to its Nasolabial Fold/Wrinkles product candi...BLA for full review. , , In a communication recei...t it had completed its initial review of the Compa...
Other Medicine Technology:One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 2One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 3One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 4One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 5One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 6Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 2Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 3
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: